• Mackenzie G. The definition and classification of pneumonia. Pneumonia. 2016;8(1):1–5.

    Article 

    Google Scholar
     

  • Medical News Today. What to know about bacterial pneumonia. 2019. Available from: https://www.medicalnewstoday.com/articles/312565.


    Google Scholar
     

  • Pahal P, Rajasurya V, Sharma S. Typical Bacterial Pneumonia. Treasure Island: StatPearls Publishing; 2020.


    Google Scholar
     

  • Temesgen D, Bereded F, Derbie A, Biadglegne F. Bacteriology of community acquired pneumonia in adult patients at Felege Hiwot referral hospital, Northwest Ethiopia: a cross-sectional study. Antimicrob Resist Infect Control. 2019;8(1):1–8.

    Article 

    Google Scholar
     

  • Shebl E, Gulick PG. Nosocomial Pneumonia. Treasure Island: StatPearls; 2020.


    Google Scholar
     

  • Eshwara V, Mukhopadhyay C, Rello J. Community-acquired bacterial pneumonia in adults: an update. Indian J Med Res. 2020;151(4):287–302.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Roth GA, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, et al. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the global burden of disease study 2017. Lancet. 2018;392(10159):1736–88.

    Article 

    Google Scholar
     

  • Cilloniz C, Martin-Loeches I, Garcia-Vidal C, San Jose A, Torres A. Microbial etiology of pneumonia: epidemiology, diagnosis and resistance patterns. Int J Mol Sci. 2016;17(12):2120.

    Article 
    CAS 
    PubMed Central 

    Google Scholar
     

  • Miyashita N, Yamauchi Y. Bacterial pneumonia in elderly Japanese populations. Jpn Clin Med. 2018;9:1179670717751433.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Ticona JH, Zaccone VM, McFarlane IM. Community-acquired pneumonia: a focused review. Am J Med Case Rep. 2021;9(1):45–52.

    Article 
    PubMed 

    Google Scholar
     

  • DerSarkissian C. What is bacterial pneumonia? 2020. Available from: https://www.webmd.com/lung/bacterial-pneumonia.


    Google Scholar
     

  • Wong JL, Evans SE. Bacterial pneumonia in patients with cancer: novel risk factors and management. Clin Chest Med. 2017;38(2):263–77.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Henig O, Kaye KS. Bacterial pneumonia in older adults. Infect Dis Clin. 2017;31(4):689–713.

    Article 

    Google Scholar
     

  • Hanada S, Pirzadeh M, Carver KY, Deng JC. Respiratory viral infection-induced microbiome alterations and secondary bacterial pneumonia. Front Immunol. 2018;9:2640.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Marangu D, Zar HJ. Childhood pneumonia in low-and-middle-income countries: an update. Paediatr Respir Rev. 2019;32:3–9.

    PubMed 
    PubMed Central 

    Google Scholar
     

  • Jean S-S, Chang Y-C, Lin W-C, Lee W-S, Hsueh P-R, Hsu C-W. Epidemiology, treatment, and prevention of nosocomial bacterial pneumonia. J Clin Med. 2020;9(1):275.

    CAS 
    Article 
    PubMed Central 

    Google Scholar
     

  • del Valle-Mendoza J, Silva-Caso W, Cornejo-Tapia A, Orellana-Peralta F, Verne E, Ugarte C, et al. Molecular etiological profile of atypical bacterial pathogens, viruses and coinfections among infants and children with community acquired pneumonia admitted to a national hospital in Lima, Peru. BMC Res Notes. 2017;10(1):1–6.

    Article 
    CAS 

    Google Scholar
     

  • Chen G, Xu K, Sun F, Sun Y, Kong Z, Fang B. Risk factors of multidrug-resistant Bacteria in lower respiratory tract infections: a systematic review and Meta-analysis. Can J Infect Dis Med Microbiol. 2020;2020:7268519.

    PubMed 
    PubMed Central 

    Google Scholar
     

  • Gao B, Li X, Yang F, Chen W, Zhao Y, Bai G, et al. Molecular epidemiology and risk factors of ventilator-associated pneumonia infection caused by carbapenem-resistant enterobacteriaceae. Front Pharmacol. 2019;10:262.

    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Cillóniz C, Dominedò C, Torres A. Multidrug resistant gram-negative bacteria in community-acquired pneumonia. Ann Update Intensive Care Emerg Med. 2019;2019:459–75.

    Article 

    Google Scholar
     

  • Sader HS, Castanheira M, Mendes RE, Flamm RK. Frequency and antimicrobial susceptibility of gram-negative bacteria isolated from patients with pneumonia hospitalized in ICUs of US medical centres (2015–17). J Antimicrob Chemother. 2018;73(11):3053–9.

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • Rouby J-J, Sole-Lleonart C, Rello J. Ventilator-associated pneumonia caused by multidrug-resistant gram-negative bacteria: understanding nebulization of aminoglycosides and colistin. Intensive Care Med. 2020;46(4):766–70.

    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Kidd JM, Kuti JL, Nicolau DP. Novel pharmacotherapy for the treatment of hospital-acquired and ventilator-associated pneumonia caused by resistant gram-negative bacteria. Expert Opin Pharmacother. 2018;19(4):397–408.

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • Cillóniz C, Dominedò C, Torres A. Multidrug resistant gram-negative bacteria in community-acquired pneumonia. Crit Care. 2019;23(1):1–9.

    Article 

    Google Scholar
     

  • Roquilly A, Torres A, Villadangos J, Netea M, Dickson R, Becher B, et al. Pathophysiological role of respiratory dysbiosis in hospital-acquired pneumonia. Lancet Respir Med. 2019;7(8):710–20.

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • Luan Y, Sun Y, Duan S, Zhao P, Bao Z. Pathogenic bacterial profile and drug resistance analysis of community-acquired pneumonia in older outpatients with fever. J Int Med Res. 2018;46(11):4596–604.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Bjarnason A, Westin J, Lindh M, Andersson L-M, Kristinsson KG, Löve A, et al. Incidence, etiology, and outcomes of community-acquired pneumonia: a population-based study. Open forum infectious diseases. US: Oxford University Press; 2018.


    Google Scholar
     

  • Sattar SBA, Sharma S. Bacterial Pneumonia. Treasure Island: StatPearls Publishing; 2020.


    Google Scholar
     

  • Malézieux-Picard A, Parent T, Roux X, Fassier T, Müller F, Prendki V. Pneumonia prevention in the elderly patients: the other sides. Aging Clin Exp Res. 2021;33(4):1091–100.

    Article 
    PubMed 

    Google Scholar
     

  • Muthumbi E, Lowe BS, Muyodi C, Getambu E, Gleeson F, Scott JAG. Risk factors for community-acquired pneumonia among adults in Kenya: a case–control study. Pneumonia. 2017;9(1):1–9.

    Article 

    Google Scholar
     

  • Jokinen J, Scott JAG. Estimating the proportion of pneumonia attributable to pneumococcus in Kenyan adults: latent class analysis. Epidemiology. 2010;21(5):719.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Onyedum CC, Chukwuka J. Admission profile and management of community acquired pneumonia in Nigeria-5 year experience in a tertiary hospital. Respir Med. 2011;105(2):298–302.

    Article 
    PubMed 

    Google Scholar
     

  • Markos Y, Dadi AF, Demisse AG, Ayanaw Habitu Y, Derseh BT, Debalkie G. Determinants of under-five pneumonia at Gondar University hospital, Northwest Ethiopia: an unmatched case-control study. J Environ Public Health. 2019;2019:1–8.

    Article 

    Google Scholar
     

  • Gordon S, Graham S. Epidemiology of respiratory disease in Malawi. Malawi Med J. 2006;18(3):134–46.

    PubMed 
    PubMed Central 

    Google Scholar
     

  • Aston SJ, Ho A, Jary H, Huwa J, Mitchell T, Ibitoye S, et al. Etiology and risk factors for mortality in an adult community-acquired pneumonia cohort in Malawi. Am J Respir Crit Care Med. 2019;200(3):359–69.

    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Ojuawo OB, Desalu OO, Fawibe AE, Ojuawo AB, Aladesanmi AO, Opeyemi CM, et al. Clinical and microbiological profile of adult inpatients with community acquired pneumonia in Ilorin, north central, Nigeria. Afr Health Sci. 2020;20(4):1655–68.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Dessie T, Jemal M, Maru M, Tiruneh M. Multiresistant bacterial pathogens causing bacterial pneumonia and analyses of potential risk factors from Northeast Ethiopia. Int J Microbiol. 2021;2021:6680343.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Assefa M, Tigabu A, Belachew T, Tessema B. Bacterial profile, antimicrobial susceptibility patterns, and associated factors of community-acquired pneumonia among adult patients in Gondar, Northwest Ethiopia: a cross-sectional study. PLoS One. 2022;17(2):e0262956.

    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Kishimbo P, Sogone NM, Kalokola F, Mshana SE. Prevalence of gram negative bacteria causing community acquired pneumonia among adults in Mwanza City, Tanzania. Pneumonia. 2020;12(1):1–9.

    Article 

    Google Scholar
     

  • Ibrahim A. Bacterial etiology of community acquired pneumonia and their antimicrobial susceptibility in patients admitted to alshaab teaching hospital. Sudan Med Lab J. 2018;6(1):78–94.


    Google Scholar
     

  • Torres A, Cillóniz C. Clinical management of bacterial pneumonia: Springer; 2015.

    Book 

    Google Scholar
     

  • Pássaro L, Harbarth S, Landelle C. Prevention of hospital-acquired pneumonia in non-ventilated adult patients: a narrative review. Antimicrob Resist Infect Control. 2016;5(1):1–11.

    Article 

    Google Scholar
     

  • Tassew SG, Alebachew Woldu M, Amogne Degu W, Shibeshi W. Management of hospital-acquired infections among patients hospitalized at Zewditu memorial hospital, Addis Ababa, Ethiopia: a prospective cross-sectional study. PLoS One. 2020;15(4):e0231949.

    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Nusrat T, Akter N, Rahman NAA, Godman BD, Rozario DT, Haque M. Antibiotic resistance and sensitivity pattern of Metallo-β-Lactamase Producing Gram-Negative Bacilli in ventilator-associated pneumonia in the intensive care unit of a public medical school hospital in Bangladesh. Hosp Pract. 2020;48(3):128–36.

    Article 

    Google Scholar
     

  • Sattar F, Quadros D, Olang P, Chokwe T. Incidence of ventilator-associated pneumonia in the critical care unit at Kenyatta National Hospital, a public tertiary care hospital. East Afr Med J. 2018;95(6):1613–23.


    Google Scholar
     

  • Saied W, Mourvillier B, Cohen Y, Ruckly S, Reignier J, Marcotte G, et al. A comparison of the mortality risk associated with ventilator-acquired bacterial pneumonia and nonventilator ICU-acquired bacterial pneumonia. Crit Care Med. 2019;47(3):345–52.

    Article 
    PubMed 

    Google Scholar
     

  • Cilloniza C, Dominedo C, Torresa A. CURRENT OPINION an overview of guidelines for the management of hospital-acquired and ventilator-associated pneumonia caused by multidrug-resistant gram-negative bacteria. Curr Opin Infect Dis. 2019;32:656–62.

    Article 

    Google Scholar
     

  • Sader HS, Farrell DJ, Flamm RK, Jones RN. Antimicrobial susceptibility of gram-negative organisms isolated from patients hospitalised with pneumonia in US and European hospitals: results from the SENTRY antimicrobial surveillance program, 2009–2012. Int J Antimicrob Agents. 2014;43(4):328–34.

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • El-Nawawy A, Ramadan MA-F, Antonios MA-M, Arafa SA-F, Hamza E. Bacteriologic profile and susceptibility pattern of mechanically ventilated paediatric patients with pneumonia. J Glob Antimicrob Resist. 2019;18:88–94.

    Article 
    PubMed 

    Google Scholar
     

  • Mazloomirad F, Hasanzadeh S, Sharifi A, Nikbakht G, Roustaei N, Khoramrooz SS. Identification and detection of pathogenic bacteria from patients with hospital-acquired pneumonia in southwestern Iran; evaluation of biofilm production and molecular typing of bacterial isolates. BMC Pulm Med. 2021;21(1):1–11.

    Article 
    CAS 

    Google Scholar
     

  • Feng D-Y, Zhou Y-Q, Zou X-L, Zhou M, Wu W-B, Chen X-X, et al. Factors influencing mortality in hospital-acquired pneumonia caused by gram-negative bacteria in China. J Infect Public Health. 2019;12(5):630–3.

    Article 
    PubMed 

    Google Scholar
     

  • Bassetti M, Righi E, Vena A, Graziano E, Russo A, Peghin M. Risk stratification and treatment of ICU-acquired pneumonia caused by multidrug-resistant/extensively drug-resistant/pandrug-resistant bacteria. Curr Opin Crit Care. 2018;24(5):385–93.

    Article 
    PubMed 

    Google Scholar
     

  • Gupta R, Malik A, Rizvi M, Ahmed M, Singh A. Epidemiology of multidrug-resistant gram-negative pathogens isolated from ventilator-associated pneumonia in ICU patients. J Glob Antimicrob Resist. 2017;9:47–50.

    Article 
    PubMed 

    Google Scholar
     

  • Yehia FAA, Serry FK, Abdullatif H, M El-Ganiny A. Prevalence and antimicrobial susceptibility of bacterial pathogens isolated from ventilator associated pneumonia (VAP) patients. Zagazig. J Pharm Sci. 2017;26(1):39–47.


    Google Scholar
     

  • Ahsan AA, Barai L, Faruq MO, Fatema K, Ahmed F, Saha DK, et al. Antibiotic resistance pattern among bacteria causing ventilator associated pneumonia in an intensive care unit of Bangladesh. Bangladesh Crit Care J. 2016;4(2):69–73.

    Article 

    Google Scholar
     

  • Nguyen TT, Nguyen KT. Hospital-acquired pneumonia in an intensive care unit in Vietnam: clinical characteristics and pathogenic bacteria. Pharmaceut Sci Asia. 2020;47(4):387–98.

    Article 

    Google Scholar
     

  • Nyawale HA. Incidence, bacteria etiology and factors associated with ventilator associated pneumonia among patients on mechanical ventilator in intensive care units at tertiary hospitals. Dar Es Salaam: Muhimbili University of Health and Allied Sciences; 2020.


    Google Scholar
     

  • Gu W-J, Wang F, Tang L, Bakker J, Liu J-C. Colistin for the treatment of ventilator-associated pneumonia caused by multidrug-resistant gram-negative bacteria: a systematic review and meta-analysis. Int J Antimicrob Agents. 2014;44(6):477–85.

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • Ruppé É, Woerther P-L, Barbier F. Mechanisms of antimicrobial resistance in gram-negative bacilli. Ann Intensive Care. 2015;5(1):1–15.

    Article 
    CAS 

    Google Scholar
     

  • Breijyeh Z, Jubeh B, Karaman R. Resistance of gram-negative bacteria to current antibacterial agents and approaches to resolve it. Molecules. 2020;25(6):1340.

    CAS 
    Article 
    PubMed Central 

    Google Scholar
     

  • Asfaw T. Review on hospital wastewater as a source of emerging drug resistance pathogens. J Res Environ Sci Toxicol. 2018;7(2):47–52.

    Article 

    Google Scholar
     

  • Cerceo E, Deitelzweig SB, Sherman BM, Amin AN. Multidrug-resistant gram-negative bacterial infections in the hospital setting: overview, implications for clinical practice, and emerging treatment options. Microb Drug Resist. 2016;22(5):412–31.

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • Maruyama T, Fujisawa T, Ishida T, Ito A, Oyamada Y, Fujimoto K, et al. A therapeutic strategy for all pneumonia patients: a 3-year prospective multicenter cohort study using risk factors for multidrug-resistant pathogens to select initial empiric therapy. Clin Infect Dis. 2019;68(7):1080–8.

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • Watkins RR, Van Duin D. Current trends in the treatment of pneumonia due to multidrug-resistant gram-negative bacteria. F1000Research. 2019;8.

  • Rubio-Perez I, Martin-Perez E, Domingo-García D, Garcia-Olmo D. Specific clinical profile and risk factors for mortality in general surgery patients with infections by multi-drug–resistant gram-negative bacteria. Surg Infect (Larchmt). 2017;18(5):625–33.

    Article 

    Google Scholar
     

  • Shindo Y, Ito R, Kobayashi D, Ando M, Ichikawa M, Shiraki A, et al. Risk factors for drug-resistant pathogens in community-acquired and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2013;188(8):985–95.

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • Prina E, Ranzani OT, Polverino E, Cillóniz C, Ferrer M, Fernandez L, et al. Risk factors associated with potentially antibiotic-resistant pathogens in community-acquired pneumonia. Ann Am Thorac Soc. 2015;12(2):153–60.

    Article 
    PubMed 

    Google Scholar
     

  • Aliberti S, Cilloniz C, Chalmers JD, Zanaboni AM, Cosentini R, Tarsia P, et al. Multidrug-resistant pathogens in hospitalised patients coming from the community with pneumonia: a European perspective. Thorax. 2013;68(11):997–9.

    Article 
    PubMed 

    Google Scholar
     

  • Eugenin EA. Community-acquired pneumonia infections by Acinetobacter baumannii: how does alcohol impact the antimicrobial functions of macrophages? Virulence. 2013;4(6):435–6.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Inghammar M, Borand L, Goyet S, Rammaert B, Te V, Lorn Try P, et al. Community-acquired pneumonia and gram-negative bacilli in Cambodia—incidence, risk factors and clinical characteristics. Trans R Soc Trop Med Hyg. 2018;112(2):57–63.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Yun Z, Hong Z, Dengchuan Z, Afang Z, Jiabin L. Risk factor analysis of pan-drug resistant Acinetobacter baumannii-induced ventilator-associated pneumonia in ICU. Indian J Pharm Sci. 2020:8–11.

  • Teramoto SYK, Hizawa N. Update on the pathogenesis and management of pneumonia in the elderly-roles of aspiration pneumonia. Respir Investig. 2015;53(5):178–84.

    Article 
    PubMed 

    Google Scholar
     

  • Wang Y-h. Current progress of research on intestinal bacterial translocation. Microb Pathog. 2021;152:104652.

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • Seki M. Emerging the notion and definition of NHCAP: what is the NHCAP? Why aspiration pneumonia is important in NHCAP? Aspiration pneumonia: Springer; 2020. p. 219–27.


    Google Scholar
     

  • Sasegbon A, Hamdy S. The anatomy and physiology of normal and abnormal swallowing in oropharyngeal dysphagia. Neurogastroenterol Motil. 2017;29(11):e13100.

    Article 

    Google Scholar
     

  • Nagpal R, Yadav H. Bacterial translocation from the gut to the distant organs: an overview. Ann Nutr Metab. 2017;71(Suppl. 1):11–6.

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • da Cruz DG, de Magalhães RF, Padilha GA, da Silva MC, Braga CL, Silva AR, et al. Impact of positive biphasic pressure during low and high inspiratory efforts in Pseudomonas aeruginosa-induced pneumonia. PLoS One. 2021;16(2):e0246891.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • de Carvalho Baptista IM, Martinho FC, Nascimento GG, da Rocha Santos CE, do Prado RF, Valera MC. Colonization of oropharynx and lower respiratory tract in critical patients: risk of ventilator-associated pneumonia. Arch Oral Biol. 2018;85:64–9.

    Article 
    PubMed 

    Google Scholar
     

  • Cepas V, Soto SM. Relationship between virulence and resistance among gram-negative bacteria. Antibiotics. 2020;9(10):719.

    CAS 
    Article 
    PubMed Central 

    Google Scholar
     

  • Viswanathan P, Suneeva S, Rathinam P. Quorum sensing in pathogenesis and virulence. Quorum sensing vs quorum quenching: a battle with no end in sight: Springer; 2015. p. 39–50.


    Google Scholar
     

  • Méndez R, Menéndez R, Cillóniz C, Amara-Elori I, Amaro R, González P, et al. Initial inflammatory profile in community-acquired pneumonia depends on time since onset of symptoms. Am J Respir Crit Care Med. 2018;198(3):370–8.

    Article 
    PubMed 

    Google Scholar
     

  • Redinger J, Albert T. Approach to dyspnea. chalk talks in internal medicine: Springer; 2020. p. 197–202.

    Book 

    Google Scholar
     

  • Franquet T. Imaging of community-acquired pneumonia. J Thorac Imaging. 2018;33(5):282–94.

    Article 
    PubMed 

    Google Scholar
     

  • Noviello S, Huang DB. The basics and the advancements in diagnosis of bacterial lower respiratory tract infections. Diagnostics. 2019;9(2):37.

    CAS 
    Article 
    PubMed Central 

    Google Scholar
     

  • Claassen CC, Keenan WJ. Challenging the “culture” of the tracheal aspirate. NeoReviews. 2019;20(3):e145–e51.

    Article 
    PubMed 

    Google Scholar
     

  • Gadsby NJ, Russell CD, McHugh MP, Mark H, Conway Morris A, Laurenson IF, et al. Comprehensive molecular testing for respiratory pathogens in community-acquired pneumonia. Clin Infect Dis. 2016;62(7):817–23.

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • Kitsios GD, Fitch A, Manatakis DV, Rapport SF, Li K, Qin S, et al. Respiratory microbiome profiling for etiologic diagnosis of pneumonia in mechanically ventilated patients. Front Microbiol. 2018;9:1413.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Akter S, Shamsuzzaman S, Jahan F. Community acquired bacterial pneumonia: aetiology, laboratory detection and antibiotic susceptibility pattern. Malays J Pathol. 2014;36(2):97–103.

    PubMed 

    Google Scholar
     

  • Peiffer-Smadja N, Bouadma L, Mathy V, Allouche K, Patrier J, Reboul M, et al. Performance and impact of a multiplex PCR in ICU patients with ventilator-associated pneumonia or ventilated hospital-acquired pneumonia. Crit Care. 2020;24(1):1–10.

    Article 

    Google Scholar
     

  • Murphy CN, Fowler R, Balada-Llasat JM, Carroll A, Stone H, Akerele O, et al. Multicenter evaluation of the BioFire FilmArray pneumonia/pneumonia plus panel for detection and quantification of agents of lower respiratory tract infection. J Clin Microbiol. 2020;58(7):e00128–0.

    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Edin A, Eilers H, Allard A. Evaluation of the Biofire Filmarray pneumonia panel plus for lower respiratory tract infections. Infect Dis. 2020;52(7):479–88.

    Article 

    Google Scholar
     

  • Acharya KP, Wilson RT. Antimicrobial resistance in Nepal. Front Med. 2019;6:105.

    Article 

    Google Scholar
     

  • Qi L, Li H, Zhang C, Liang B, Li J, Wang L, et al. Relationship between antibiotic resistance, biofilm formation, and biofilm-specific resistance in Acinetobacter baumannii. Front Microbiol. 2016;7:483.

    PubMed 
    PubMed Central 

    Google Scholar
     

  • Arzanlou M, Chai WC, Venter H. Intrinsic, adaptive and acquired antimicrobial resistance in gram-negative bacteria. Essays Biochem. 2017;61(1):49–59.

    Article 
    PubMed 

    Google Scholar
     

  • Eichenberger EM, Thaden JT. Epidemiology and mechanisms of resistance of extensively drug resistant gram-negative bacteria. Antibiotics. 2019;8(2):37.

    CAS 
    Article 
    PubMed Central 

    Google Scholar
     

  • Öztürk H, Ozkirimli E, Özgür A. Classification of beta-lactamases and penicillin binding proteins using ligand-centric network models. PLoS One. 2015;10(2):e0117874.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Bandić-Pavlović D, Zah-Bogović T, Žižek M, Bielen L, Bratić V, Hrabač P, et al. Gram-negative bacteria as causative agents of ventilator-associated pneumonia and their respective resistance mechanisms. J Chemother. 2020;32(7):344–58.

    Article 
    PubMed 

    Google Scholar
     

  • Bonomo RA. β-Lactamases: a focus on current challenges. Cold Spring Harb Perspect Med. 2017;7(1):a025239.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Dumaru R, Baral R, Shrestha LB. Study of biofilm formation and antibiotic resistance pattern of gram-negative Bacilli among the clinical isolates at BPKIHS. Dharan BMC Res Notes. 2019;12(1):1–6.

    Article 

    Google Scholar
     

  • Baidya S, Sharma S, Mishra SK, Kattel HP, Parajuli K, Sherchand JB. Biofilm formation by pathogens causing ventilator-associated pneumonia at intensive care units in a tertiary care hospital: an armor for refuge. Biomed Res Int. 2021;2021:1–10.

    Article 
    CAS 

    Google Scholar
     

  • Stets R, Popescu M, Gonong JR, Mitha I, Nseir W, Madej A, et al. Omadacycline for community-acquired bacterial pneumonia. N Engl J Med. 2019;380(6):517–27.

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • File TM Jr, Goldberg L, Das A, Sweeney C, Saviski J, Gelone SP, et al. Efficacy and safety of intravenous-to-oral lefamulin, a pleuromutilin antibiotic, for the treatment of community-acquired bacterial pneumonia: the phase III lefamulin evaluation against pneumonia (LEAP 1) trial. Clin Infect Dis. 2019;69(11):1856–67.

    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • McCurdy S, Keedy K, Lawrence L, Nenninger A, Sheets A, Quintas M, et al. Efficacy of delafloxacin versus moxifloxacin against bacterial respiratory pathogens in adults with community-acquired bacterial pneumonia (CABP): microbiology results from the delafloxacin phase 3 CABP trial. Antimicrob Agents Chemother. 2020;64(3):e01949–19.

    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Vardakas KZ, Trigkidis K, Falagas M. Fluoroquinolones or macrolides in combination with β-lactams in adult patients hospitalized with community acquired pneumonia: a systematic review and meta-analysis. Clin Microbiol Infect. 2017;23(4):234–41.

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • Wunderink RG, Matsunaga Y, Ariyasu M, Clevenbergh P, Echols R, Kaye KS, et al. Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind, phase 3, non-inferiority trial. Lancet Infect Dis. 2021;21(2):213–25.

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • Torres A, Rank D, Melnick D, Rekeda L, Chen X, Riccobene T, et al. Randomized trial of ceftazidime-avibactam vs meropenem for treatment of hospital-acquired and ventilator-associated bacterial pneumonia (REPROVE): analyses per US FDA–specified end points. Open forum infectious diseases. US: Oxford University Press; 2019.


    Google Scholar
     

  • Titov I, Wunderink RG, Roquilly A, Rodríguez Gonzalez D, David-Wang A, Boucher HW, et al. A randomized, double-blind, multicenter trial comparing efficacy and safety of imipenem/cilastatin/relebactam versus piperacillin/tazobactam in adults with hospital-acquired or ventilator-associated bacterial pneumonia (RESTORE-IMI 2 Study). Clin Infect Dis. 2021;73(11):e4539–48.

  • Liscio JL, Mahoney MV, Hirsch EB. Ceftolozane/tazobactam and ceftazidime/avibactam: two novel β-lactam/β-lactamase inhibitor combination agents for the treatment of resistant gram-negative bacterial infections. Int J Antimicrob Agents. 2015;46(3):266–71.

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • Chang Liu Y-TZ, Peng Z-Y, Zhou Q, Hu B, Zhou H, Li J-G. Aerosolized amikacin as adjunctive therapy of ventilator-associated pneumonia caused by multidrug-resistant gram-negative bacteria: a single-center randomized controlled trial. Chin Med J (Engl). 2017;130(10):1196–201.

    Article 
    CAS 

    Google Scholar
     

  • Aygun F, Aygun FD, Varol F, Durak C, Cokugraş H, Camcioglu Y, et al. Can nebulised Colistin therapy improve outcomes in critically ill children with multi-drug resistant gram-negative bacterial pneumonia? Antibiotics. 2019;8(2):40.

    CAS 
    Article 
    PubMed Central 

    Google Scholar
     

  • Feng JY, Peng CK, Sheu CC, Lin YC, Chan MC, Wang SH, et al. Efficacy of adjunctive nebulized colistin in critically ill patients with nosocomial carbapenem-resistant Gram-negative bacterial pneumonia: a multi-centre observational study. Clin Microbiol Infect. 2021;27(10):1465–73.

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • Abdellatif S, Trifi A, Daly F, Mahjoub K, Nasri R, Lakhal SB. Efficacy and toxicity of aerosolised colistin in ventilator-associated pneumonia: a prospective, randomised trial. Ann Intensive Care. 2016;6(1):1–11.

    Article 

    Google Scholar
     

  • Manohar P, Nachimuthu R, Lopes BS. The therapeutic potential of bacteriophages targeting gram-negative bacteria using galleria mellonella infection model. BMC Microbiol. 2018;18(1):1–11.

    Article 
    CAS 

    Google Scholar
     

  • Lood R, Winer BY, Pelzek AJ, Diez-Martinez R, Thandar M, Euler CW, et al. Novel phage lysin capable of killing the multidrug-resistant gram-negative bacterium Acinetobacter baumannii in a mouse bacteremia model. Antimicrob Agents Chemother. 2015;59(4):1983–91.

    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Anand T, Virmani N, Kumar S, Mohanty AK, Pavulraj S, Bera BC, et al. Phage therapy for treatment of virulent Klebsiella pneumoniae infection in a mouse model. J Glob Antimicrob Resist. 2020;21:34–41.

    Article 
    PubMed 

    Google Scholar
     

  • Raz A, Serrano A, Hernandez A, Euler CW, Fischetti VA. Isolation of phage lysins that effectively kill Pseudomonas aeruginosa in mouse models of lung and skin infection. Antimicrob Agents Chemother. 2019;63(7):e00024–19.

    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Huang L, Huang S, Jiang L, Tan J, Yan X, Gou C, et al. Characterization and sequencing of a novel phage Abp95 against multi-genotypes of Carbapenem-resistant Acinetobacter baumannii. 2021.

    Book 

    Google Scholar
     

  • Zhang Y, Meng B, Wei X, Li Y, Wang X, Zheng Y, et al. Evaluation of phage therapy for pulmonary infection of mouse by liquid aerosol-exposure Pseudomonas aeruginosa. Infect Drug Resist. 2021;14:4457.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Bann SJ, Ballantine RD, Cochrane SA. The tridecaptins: non-ribosomal peptides that selectively target gram-negative bacteria. RSC Med Chem. 2021;12(4):538–51.

    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Pantel L, Florin T, Dobosz-Bartoszek M, Racine E, Sarciaux M, Serri M, et al. Odilorhabdins, antibacterial agents that cause miscoding by binding at a new ribosomal site. Mol Cell. 2018;70(1):83–94. e7.

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • Zhang J, Liang X, Zhang S, Song Z, Wang C, Xu Y, et al. A novel natural compound with promising anti-biofilm activity against gram-negative pathogenic bacteria. Front Microbiol. 2021;11:3480.


    Google Scholar
     

  • Islam S, Chisti MJ, Ahmed M, Anwar N, Lehmann C. Bacterial resistance in pneumonia in developing countries—a role for Iron chelation. Trop Med Infect Dis. 2019;4(2):59.

    Article 
    PubMed Central 

    Google Scholar
     

  • Opoku-Temeng CKS, DeLeo FR. Klebsiella pneumoniae capsule polysaccharide as a target for therapeutics and vaccines. Comput Struct Biotechnol J. 2019;1(17):1360–6.

    Article 
    CAS 

    Google Scholar
     

  • Rodrigues MX, Yang Y, de Souza Meira EB Jr, do Carmo Silva J, Bicalho RC. Development and evaluation of a new recombinant protein vaccine (YidR) against Klebsiella pneumoniae infection. Vaccine. 2020;38(29):4640–8.

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • Feldman MF, Bridwell AEM, Scott NE, Vinogradov E, McKee SR, Chavez SM, et al. A promising bioconjugate vaccine against hypervirulent Klebsiella pneumoniae. Proc Natl Acad Sci. 2019;116(37):18655–63.

    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Kumar A, Harjai K, Chhibber S. Early cytokine response to lethal challenge of Klebsiella pneumoniae averted the prognosis of pneumonia in FyuA immunized mice. Microb Pathog. 2020;144:104161.

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • Adlbrecht C, Wurm R, Depuydt P, Spapen H, Lorente JA, Staudinger T, et al. Efficacy, immunogenicity, and safety of IC43 recombinant Pseudomonas aeruginosa vaccine in mechanically ventilated intensive care patients—a randomized clinical trial. Crit Care. 2020;24(1):1–10.

    Article 

    Google Scholar
     

  • Cabral MP, Correia A, Vilanova M, Gärtner F, Moscoso M, García P, et al. A live auxotrophic vaccine confers mucosal immunity and protection against lethal pneumonia caused by Pseudomonas aeruginosa. PLoS Pathog. 2020;16(2):e1008311.

    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Gajdács M, Urbán E. Prevalence and antibiotic resistance of Stenotrophomonas maltophilia in respiratory tract samples: a 10-year epidemiological snapshot. Health Serv Res Manag Epidemiol. 2019;6:2333392819870774.

    PubMed 
    PubMed Central 

    Google Scholar
     

  • Shah MD, Coe KE, El Boghdadly Z, Wardlow LC, Dela-Pena JC, Stevenson KB, et al. Efficacy of combination therapy versus monotherapy in the treatment of Stenotrophomonas maltophilia pneumonia. J Antimicrob Chemother. 2019;74(7):2055–9.

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • Guerci P, Bellut H, Mokhtari M, Gaudefroy J, Mongardon N, Charpentier C, et al. Outcomes of Stenotrophomonas maltophilia hospital-acquired pneumonia in intensive care unit: a nationwide retrospective study. Crit Care. 2019;23(1):1–13.

    Article 

    Google Scholar
     

  • Saied WI, Merceron S, Schwebel C, Le Monnier A, Oziel J, Garrouste-Orgeas M, et al. Ventilator-associated pneumonia due to Stenotrophomonas maltophilia: risk factors and outcome. J Infect. 2020;80(3):279–85.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Canivet C, Teysseyre L, Aujoulat T, Caron M, Nativel M, Miltgen G, et al. Risk factors for a first episode of ventilator-associated pneumonia caused by Stenotrophomonas maltophilia. 2022.

    Book 

    Google Scholar
     

  • Imoto W, Kaneko Y, Yamada K, Kuwabara G, Yamairi K, Shibata W, et al. A mouse model of rapidly progressive fatal haemorrhagic pneumonia caused by Stenotrophomonas maltophilia. J Glob Antimicrob Resist. 2020;23:450–5.

    Article 
    PubMed 

    Google Scholar
     

  • Velázquez-Acosta C, Zarco-Márquez S, Jiménez-Andrade MC, Volkow-Fernández P, Cornejo-Juárez P. Stenotrophomonas maltophilia bacteremia and pneumonia at a tertiary-care oncology center: a review of 16 years. Support Care Cancer. 2018;26(6):1953–60.

    Article 
    PubMed 

    Google Scholar
     

  • Kim S-H, Cha MK, Kang C-I, Ko J-H, Huh K, Cho SY, et al. Pathogenic significance of hemorrhagic pneumonia in hematologic malignancy patients with Stenotrophomonas maltophilia bacteremia: clinical and microbiological analysis. Eur J Clin Microbiol Infect Dis. 2019;38(2):285–95.

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • Zha L, Zhang D, Pan L, Ren Z, Li X, Zou Y, et al. Tigecycline in the treatment of ventilator-associated pneumonia due to Stenotrophomonas maltophilia: a multicenter retrospective cohort study. Infect Dis Ther. 2021;10(4):2415–29.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Rights and permissions

    Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

    Disclaimer:

    This article is autogenerated using RSS feeds and has not been created or edited by OA JF.

    Click here for Source link (https://www.biomedcentral.com/)